Ambry Genetics is a genetic testing laboratory founded in 1999 and headquartered in Aliso Viejo, California. Its work sits at the intersection of genomics and clinical diagnostics, applying sequencing and analysis techniques to hereditary cancer risk assessment and rare disease diagnosis. The laboratory has completed more than one million genetic tests and maintains a staff of over 100 genetic counselors supporting patients, healthcare providers and clinicians worldwide.
The company's technical work spans exome sequencing, hereditary cancer panels and paired RNA and DNA testing, an approach intended to improve diagnostic accuracy and yield for patients on complex diagnostic journeys. Its stated aim is to translate scientific research into clinically actionable test results, and it was founded with a commitment to restoring the balance between open science and commercial healthcare innovation.
Operating for over 25 years, Ambry Genetics works across the genetic testing, healthcare and life sciences sectors, with a focus on high-quality, accessible genetic testing services. Further information is available at https://ambrygen.com/.
